Is BMAC the Same as Micronized Fat?
What Patients in Gilbert, Arizona Should Know
Quick Answer
The short answer is no. Both are autologous cellular options, but they come from different tissues and fit different clinical situations.
BMAC and micronized fat are two of the more biologically active regenerative options patients ask about at Solutions Regenerative Medicine in Gilbert, Arizona. They are not the same treatment. They come from different source tissues, carry overlapping but distinct biological components, and fit different clinical situations. Dr. Mareshah Dunning uses both as part of a broader regenerative plan that may also include prolotherapy, PRP, A2M, and donor tissue.
What Is Micronized Fat and What Is BMAC?
Both are autologous cellular preparations, meaning they are made from your own tissue and returned to you the same day. The difference is the source tissue and the harvest technique.
Micronized Fat
Micronized fat is drawn from your own adipose (fat) tissue, typically from the abdomen or flank using a closed, water-assisted harvest system (body-jet® eco). The tissue is then processed to break the fat into small clusters that retain the supportive cellular components of adipose tissue. Adipose is one of the naturally richest reservoirs of mesenchymal stem cell populations in the body, and micronized fat also provides structural cushioning for the injected area.
BMAC (Bone Marrow Aspirate Concentrate)
BMAC is drawn from your own bone marrow, typically from the back of the pelvis under local numbing. The marrow is processed onsite using a closed system dual spin concentrator. Bone marrow carries a uniquely rich biological reserve, including two coexisting stem cell populations (mesenchymal and hematopoietic) along with bone-marrow-specific signaling molecules and strong anti-inflammatory cytokines that neither blood nor adipose tissue delivers. This combination is what makes BMAC a distinct upper-tier option rather than simply a richer version of PRP.
How Are BMAC and Micronized Fat Similar?
The two treatments share more in common than they differ in mechanism.
- Both are autologous, made from your own tissue and prepared and injected during the same office visit.
- Both are delivered under real time ultrasound or fluoroscopy guidance.
- Both draw on stem cell populations naturally present in the source tissue and work with the body’s own healing pathways rather than suppressing symptoms.
- Both have favorable safety profiles across published clinical use.
- Both can be banked so a portion of the concentrate can be preserved for future use as part of a longer term treatment strategy.
- Anti inflammatory medications like ibuprofen and naproxen are held for at least seven days after either treatment so the biology can do its work.
How Are BMAC and Micronized Fat Different?
The two treatments differ in the specific biological components each one is enriched in, in the harvest technique, and in the recovery pattern that follows.
- Components unique to BMAC: hematopoietic stem cells (which contribute to new blood vessel formation), and the bone marrow specific signaling molecules BMP-2 (drives new bone formation) and SDF-1α (recruits additional circulating stem cells to the injured area).
- Components unique to micronized fat: preserved intact pericyte and microvessel architecture from the source tissue, higher cellularity per volume than BMAC, a paracrine secretome prominently enriched in HGF and TGF-β, and microRNA signatures shown to protect cartilage in osteoarthritis and shift immune cells at the injection site from a destructive inflammatory state to a reparative, anti inflammatory one.
- Scaffolding at the injection site: micronized fat provides a persistent adipose scaffold that physically cushions the area where it is injected; BMAC creates a temporary fibrin scaffold from platelet activation that supports cell attachment and early healing before being resorbed.
- Age preservation of cell yield: micronized fat holds up better with age; BMAC cell yield declines more steeply with age.
- Harvest: micronized fat is a closed, water-assisted liposuction from the abdomen or flank under local anesthesia (a longer harvest that generates more material); BMAC is a bone marrow aspiration from the back of the pelvis under local numbing, most often described as a deep pressure or pulling feeling.
- Recovery: micronized fat has about two weeks of reduced strenuous activity due to the liposuction harvest, with an abdominal binder worn during that time and no submersion in water (baths, pools, hot tubs) until the harvest sites are healed, plus one to three days of injection site soreness; BMAC has one to three days of harvest and injection site soreness for most, up to seven to ten days for some, with quick return to activity.
Quick Comparison: BMAC vs Micronized Fat at a Glance
The table below summarizes the full comparison.
Feature | Micronized Fat | BMAC |
Source tissue | Adipose (abdomen or flank) | Bone marrow (back of the pelvis) |
Mesenchymal stem cell populations | Present | Present |
Hematopoietic stem and progenitor cells | Not present | Present, unique to BMAC |
General growth factors (VEGF, PDGF, FGF, IGF) | Elevated | Elevated |
Interleukin-1 receptor antagonist (IL-1Ra, a natural blocker of the inflammation that drives cartilage breakdown) | Elevated | Elevated |
Hepatocyte growth factor (HGF) and transforming growth factor beta (TGF-β) | Higher, prominent in the MFAT secretome, supports tissue regeneration and anti-fibrotic remodeling | Present |
Bone morphogenetic protein 2 (BMP-2) and stromal cell derived factor 1 alpha (SDF-1α) | Not present | Higher, bone-marrow specific, supports bone formation and stem cell recruitment |
Extracellular vesicle and microRNA cargo (cartilage-protective signaling) | Prominent | Present |
Support for angiogenesis (new blood vessel formation, the biology that restores blood flow to injured tissue) | Present | Higher, combines platelet-derived angiogenic factors with hematopoietic progenitor cells and stem cell recruitment signaling (SDF-1α) |
Structural scaffold at injection site | Persistent adipose cushioning | Temporary fibrin scaffold from platelets |
Preservation of the microvessel and pericyte architecture | Preserved intact | Not preserved, cells delivered individually |
Age effect on cell yield | Holds up better with age | Declines more steeply with age |
Best fit clinical picture | Soft tissue and cartilage indications; when a bone marrow harvest is not preferred; when adipose availability supports a comfortable harvest | Bone-side injury (non-healing fracture, avascular necrosis, subchondral bone edema); nerve pathology where angiogenesis is a treatment target; younger patients; patients without enough adiposity for a fat harvest |
Harvest experience | Water-assisted liposuction under local anesthesia | Bone marrow aspiration under local anesthesia |
Recovery pattern | About two weeks of reduced strenuous activity due to the liposuction harvest, plus one to three days of injection site soreness | One to three days of harvest and injection site soreness for most, up to seven to ten days for some; return to activity typically quick |
Typical cost tier | Upper | Upper |
When Is Each One the Preferred Choice?
At Solutions Regenerative Medicine, micronized fat is generally Dr. Dunning’s preferred upper tier injection because of its cellularity per volume, its persistent adipose scaffold, its preserved pericyte and microvessel architecture, and a cell yield that holds up better with age than bone marrow does. It is a strong default fit for load bearing joints, cartilage focused indications, soft tissue indications like tendon and ligament healing, patients whose adipose availability supports a comfortable harvest, and patients meaningfully past their mid 40s.
BMAC becomes the preferred choice when specific case factors call for it. That includes bone side pathology (non healing fractures, avascular necrosis, subchondral bone edema, cartilage indications where the underlying bone matters), cases where new blood vessel formation is central to the healing plan (including neuropathies and other nerve pathology, where restoring blood supply to injured nerves through VEGF driven angiogenesis is a treatment target), patients who do not have enough adiposity for a comfortable micronized fat harvest, younger patients where marrow yield is still robust, and situations where PRP has been tried and the clinical picture calls for an uplevel with bone marrow specific components.
The decision starts with a full evaluation, a review of your history and imaging, and often a diagnostic injection sequence to confirm the true pain generator before advancing to the more involved regenerative treatments. Cost is typically not a differentiator between the two; BMAC and micronized fat are comparable in cost at Solutions Regenerative Medicine, so the decision comes down to the biology and the fit for your specific case. Dr. Dunning often sequences BMAC and micronized fat with other regenerative options like PRP and A2M across a broader treatment plan.
Frequently Asked Questions
Is micronized fat a stem cell treatment?
Adipose tissue is one of the naturally richest reservoirs of mesenchymal stem cell populations in the body, and micronized fat carries those components into the injected area. However, the therapeutic goal of micronized fat is to support your body’s own healing response rather than to introduce cells that grow into new tissue. Dr. Dunning discusses realistic expectations during your consultation.
Which one has more stem cells, BMAC or micronized fat?
Both bone marrow and adipose tissue naturally contain mesenchymal stem cell populations. Adipose tends to carry a higher concentration of mesenchymal stem cells per volume, while bone marrow uniquely carries the hematopoietic stem cell line. The right question is not which has more of one cell type, but which biological signature fits the injury and the patient.
Can BMAC and micronized fat be combined?
Yes. BMAC and micronized fat can be combined in the same procedure when the clinical picture calls for both the bone marrow specific biology BMAC delivers and the structural and cellular signature micronized fat delivers, and they can also be sequenced across a broader treatment plan. Which approach fits your case is a conversation Dr. Dunning has with you during your consultation.
Is one covered by insurance?
Neither BMAC nor micronized fat is generally covered by commercial insurance, Medicare, or Medicaid for musculoskeletal indications. Both are typically out of pocket, and the two are comparable in cost at Solutions Regenerative Medicine, so cost is generally not a decision point between them. HSA funds can usually be applied, and superbills may be available for you to submit to your insurer, though reimbursement is not guaranteed. Costs are discussed transparently during your consultation.
Book a consultation with Dr. Mareshah Dunning at Solutions Regenerative Medicine in Gilbert, Arizona. Book online or call (480) 995-9131.